STOCK TITAN

Vita Coco (NASDAQ: COCO) CCO sells 2,000 shares under Rule 10b5-1 plan

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 2,000 shares of Common Stock at $66.87 per share. Following this sale, he directly holds 75,691 Common Stock shares. The filing also lists multiple outstanding non-qualified stock options that are vested or scheduled to vest over time, with exercise prices ranging from $10.178 to $33.36 per share and expiration dates extending through 2035. A footnote states the sale was executed under a pre-arranged Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.
Insider van Es Charles
Role Chief Commercial Officer
Sold 2,000 shs ($134K)
Type Security Shares Price Value
Sale Common Stock 2,000 $66.87 $134K
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
Holdings After Transaction: Common Stock — 75,691 shares (Direct, null); Non-Qualified Stock Option (Right to Buy) — 53,750 shares (Direct, null)
Footnotes (1)
  1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in three equal annual installments beginning on August 15, 2025. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026. The stock options vest in four annual equal installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Shares sold 2,000 shares Open-market sale of Common Stock
Sale price $66.87 per share Price for 2,000-share Common Stock sale
Shares held after sale 75,691 shares Direct Common Stock holdings post-transaction
Option exercise price $33.36 Non-qualified stock option, expires March 4, 2035
Option underlying shares 13,218 shares Underlying Common Stock for $33.36 option
Largest option block 58,043 shares Underlying Common Stock at $15.00 exercise price
Performance-vested options 14,025 shares Options that vested after performance conditions met on Feb. 20, 2026
Rule 10b5-1 trading plan regulatory
"The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Non-Qualified Stock Option (Right to Buy) financial
"security_title: Non-Qualified Stock Option (Right to Buy)"
performance conditions financial
"The stock option is eligible to vest if certain performance conditions are met by the target date"
beneficially owned financial
"total_shares_following_transaction: 75691.0000"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
van Es Charles

(Last)(First)(Middle)
111 5TH AVENUE
2ND FLOOR

(Street)
NEW YORK NEW YORK 10003

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Commercial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/01/2026S(1)2,000D$66.8775,691D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (Right to Buy)$10.178 (2)02/10/2030Common Stock53,75053,750D
Non-Qualified Stock Option (Right to Buy)$10.178 (2)01/11/2031Common Stock27,30027,300D
Non-Qualified Stock Option (Right to Buy)$15 (3)10/21/2031Common Stock58,04358,043D
Non-Qualified Stock Option (Right to Buy)$15.36 (4)08/15/2032Common Stock42,98042,980D
Non-Qualified Stock Option (Right to Buy)$16.91 (5)03/10/2033Common Stock14,02514,025D
Non-Qualified Stock Option (Right to Buy)$16.91 (6)03/10/2033Common Stock14,20514,205D
Non-Qualified Stock Option (Right to Buy)$26.18 (7)03/04/2034Common Stock8,7468,746D
Non-Qualified Stock Option (Right to Buy)$33.36 (8)03/04/2035Common Stock13,21813,218D
Explanation of Responses:
1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. The stock option is fully vested and currently exercisable.
3. The stock option vests in four equal annual installments beginning on November 27, 2022.
4. The stock option vests in three equal annual installments beginning on August 15, 2025.
5. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
6. The stock options vest in four annual equal installments beginning on March 10, 2024.
7. The stock option vests in four equal annual installments beginning on March 4, 2025.
8. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
/s/ Alison Klein, attorney-in-fact for Charles van Es05/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Vita Coco (COCO) report for Charles van Es?

Vita Coco reported that Chief Commercial Officer Charles van Es sold 2,000 shares of Common Stock in an open-market transaction at $66.87 per share, according to a Form 4 insider filing with the SEC.

How many Vita Coco (COCO) shares does Charles van Es hold after this Form 4 sale?

After selling 2,000 shares, Charles van Es directly holds 75,691 shares of Vita Coco Common Stock. This post-transaction ownership figure is disclosed in the Form 4 as the total shares beneficially owned following the reported sale.

Was the Vita Coco (COCO) insider sale by Charles van Es under a Rule 10b5-1 plan?

Yes. A footnote explains that the reported sale of Vita Coco Common Stock by Charles van Es was executed pursuant to a Rule 10b5-1 trading plan, indicating the transaction was pre-arranged rather than timed discretionarily.

What stock options does Charles van Es hold in Vita Coco (COCO) according to this filing?

The filing lists several non-qualified stock options on Vita Coco Common Stock, including grants with exercise prices such as $33.36, $26.18, $16.91, $15.36, $15.00, and $10.178, each with specified underlying share amounts and expiration dates through 2035.

Are any of Charles van Es’s Vita Coco (COCO) stock options performance-based?

Yes. One option grant is described as performance-based, with vesting tied to meeting certain performance conditions. The filing notes these conditions were satisfied, resulting in vesting of options covering 14,025 shares on February 20, 2026.

How do Charles van Es’s Vita Coco (COCO) options vest over time?

Several Vita Coco option grants to Charles van Es vest in equal annual installments over three or four years, beginning on specific dates such as November 27, 2022, August 15, 2025, March 10, 2024, and March 4, 2025, subject to continued service.